Phenotypic Heterogeneity of ADTKD-MUC1 Diagnosed Using VNtyper, a Novel Genetic Technique

IF 8.2 1区 医学 Q1 UROLOGY & NEPHROLOGY American Journal of Kidney Diseases Pub Date : 2025-05-01 Epub Date: 2025-01-22 DOI:10.1053/j.ajkd.2024.11.010
Jessica Kachmar , Hassan Saei , Vincent Morinière , Laurence Heidet , Bertrand Knebelmann , Olivier Gribouval , Manon Mautret-Godefroy , Stéphane Burtey , Vincent Vuiblet , Asma Alla , Axel Ibalanky , Olivier Moranne , Mathilde Nizon , Benjamin Savenkoff , Patrick Nitschké , Corinne Antignac , Guillaume Dorval
{"title":"Phenotypic Heterogeneity of ADTKD-MUC1 Diagnosed Using VNtyper, a Novel Genetic Technique","authors":"Jessica Kachmar ,&nbsp;Hassan Saei ,&nbsp;Vincent Morinière ,&nbsp;Laurence Heidet ,&nbsp;Bertrand Knebelmann ,&nbsp;Olivier Gribouval ,&nbsp;Manon Mautret-Godefroy ,&nbsp;Stéphane Burtey ,&nbsp;Vincent Vuiblet ,&nbsp;Asma Alla ,&nbsp;Axel Ibalanky ,&nbsp;Olivier Moranne ,&nbsp;Mathilde Nizon ,&nbsp;Benjamin Savenkoff ,&nbsp;Patrick Nitschké ,&nbsp;Corinne Antignac ,&nbsp;Guillaume Dorval","doi":"10.1053/j.ajkd.2024.11.010","DOIUrl":null,"url":null,"abstract":"<div><h3>Rationale &amp; Objective</h3><div>Molecular diagnosis of autosomal dominant tubulointerstitial kidney disease (ADTKD) due to variants in the <em>MUC1</em> gene has long been challenging because variants lie in a large variable number of tandem repeat (VNTR) region, making identification impossible using standard short-read techniques. Previously, we addressed this diagnostic limitation by developing a computational pipeline named VNtyper for easier reliable detection of <em>MUC1</em> VNTR pathogenic variants from short-read sequences. This led to unexpected diagnoses of ADTKD-<em>MUC1</em> among patients with kidney disease referred for genetic testing, which we report here.</div></div><div><h3>Study Design</h3><div>Cross-sectional observational study.</div></div><div><h3>Setting &amp; Participants</h3><div>4,040 patients referred to Necker Enfants-Malades Hospital from 2017 to 2023 for genetic testing for (1) glomerular disease, (2) ciliopathy, (3) congenital anomalies of the kidneys and urinary tracts (CAKUT), (4) ADTKD, or (5) chronic kidney disease (CKD) of unknown origin, in whom <em>MUC1</em> had not been previously tested by SNaPshot minisequencing.</div></div><div><h3>Exposure</h3><div>Clinical suspicion of ADTKD.</div></div><div><h3>Outcome</h3><div>ADTKD-<em>MUC1</em> diagnosed using VNtyper.</div></div><div><h3>Analytical Approach</h3><div>Data were collected from patients in whom ADTKD-<em>MUC1</em> was newly diagnosed and patients in whom ADTKD was clinically suspected were compared with those in whom ADTKD was not.</div></div><div><h3>Results</h3><div>We identified 40 patients with <em>MUC1</em> variants by VNtyper, including 33 new index patients and 7 relatives. Of the 33 index cases, 20 had been suspected of having ADTKD based on clinical features, and in the other 13 ADTKD had not been considered. In patients in whom ADTKD had not been considered clinically, the detection rate was 0.05% (1 of 1,895) among patients with glomerular disease, 1.2% (4 of 329) among patients with ciliopathy, 0.09% (1 of 1,099) among patients with CAKUT and 2.5% (7 of 285) among patients with CKD of unknown origin. In 6 patients there was no family history of kidney disease, and we confirmed de novo presentation in 2 patients by segregation studies.</div></div><div><h3>Limitations</h3><div>Observational study and selected referral population (may not represent the prevalence or phenotypes in the general kidney disease population).</div></div><div><h3>Conclusions</h3><div>With VNtyper, we were able to diagnose new cases of ADTKD-<em>MUC1</em> in a large cohort of patients with various phenotypes. Some patients had atypical phenotypes due to a variant in another gene, and some had no family history of kidney disease, suggesting de novo disease, which was confirmed in 2 patients.</div></div><div><h3>Plain-Language Summary</h3><div>Molecular diagnosis of autosomal dominant tubulointerstitial kidney disease due to variants in the <em>MUC1</em> gene (ADTKD-<em>MUC1</em>) has long been challenging. Recently, we developed a computational pipeline named VNtyper to allow easier, reliable detection of <em>MUC1</em> variants. When applied to a large heterogenous cohort of patients, it allowed us to diagnose ADTKD in patients in whom it had not been suspected. In some cases, this was due to 2 concomitant genetic diagnoses, which affected the phenotype. In others, there was no family history of kidney disease suggestive of an autosomal dominant disorder, and we were able to confirm de novo ADTKD-<em>MUC1</em> in 2 patients.</div></div>","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"85 5","pages":"Pages 603-609.e1"},"PeriodicalIF":8.2000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Kidney Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0272638625000381","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/22 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale & Objective

Molecular diagnosis of autosomal dominant tubulointerstitial kidney disease (ADTKD) due to variants in the MUC1 gene has long been challenging because variants lie in a large variable number of tandem repeat (VNTR) region, making identification impossible using standard short-read techniques. Previously, we addressed this diagnostic limitation by developing a computational pipeline named VNtyper for easier reliable detection of MUC1 VNTR pathogenic variants from short-read sequences. This led to unexpected diagnoses of ADTKD-MUC1 among patients with kidney disease referred for genetic testing, which we report here.

Study Design

Cross-sectional observational study.

Setting & Participants

4,040 patients referred to Necker Enfants-Malades Hospital from 2017 to 2023 for genetic testing for (1) glomerular disease, (2) ciliopathy, (3) congenital anomalies of the kidneys and urinary tracts (CAKUT), (4) ADTKD, or (5) chronic kidney disease (CKD) of unknown origin, in whom MUC1 had not been previously tested by SNaPshot minisequencing.

Exposure

Clinical suspicion of ADTKD.

Outcome

ADTKD-MUC1 diagnosed using VNtyper.

Analytical Approach

Data were collected from patients in whom ADTKD-MUC1 was newly diagnosed and patients in whom ADTKD was clinically suspected were compared with those in whom ADTKD was not.

Results

We identified 40 patients with MUC1 variants by VNtyper, including 33 new index patients and 7 relatives. Of the 33 index cases, 20 had been suspected of having ADTKD based on clinical features, and in the other 13 ADTKD had not been considered. In patients in whom ADTKD had not been considered clinically, the detection rate was 0.05% (1 of 1,895) among patients with glomerular disease, 1.2% (4 of 329) among patients with ciliopathy, 0.09% (1 of 1,099) among patients with CAKUT and 2.5% (7 of 285) among patients with CKD of unknown origin. In 6 patients there was no family history of kidney disease, and we confirmed de novo presentation in 2 patients by segregation studies.

Limitations

Observational study and selected referral population (may not represent the prevalence or phenotypes in the general kidney disease population).

Conclusions

With VNtyper, we were able to diagnose new cases of ADTKD-MUC1 in a large cohort of patients with various phenotypes. Some patients had atypical phenotypes due to a variant in another gene, and some had no family history of kidney disease, suggesting de novo disease, which was confirmed in 2 patients.

Plain-Language Summary

Molecular diagnosis of autosomal dominant tubulointerstitial kidney disease due to variants in the MUC1 gene (ADTKD-MUC1) has long been challenging. Recently, we developed a computational pipeline named VNtyper to allow easier, reliable detection of MUC1 variants. When applied to a large heterogenous cohort of patients, it allowed us to diagnose ADTKD in patients in whom it had not been suspected. In some cases, this was due to 2 concomitant genetic diagnoses, which affected the phenotype. In others, there was no family history of kidney disease suggestive of an autosomal dominant disorder, and we were able to confirm de novo ADTKD-MUC1 in 2 patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
利用新型遗传技术VNtyper诊断ADTKD-MUC1表型异质性
理由与目的:MUC1基因变异引起的常染色体显性小管间质肾病(ADTKD)的分子诊断长期以来一直具有挑战性,因为变异位于较大的可变数串联重复序列(VNTR)区域,因此无法使用标准的短读技术进行鉴定。在此之前,我们通过开发一种名为VNtyper的计算管道来解决这一诊断限制,从而更容易可靠地检测短读序列中的MUC1 VNTR致病变异。这导致在进行基因检测的肾脏疾病患者中意外诊断出ADTKD-MUC1,我们在此报道。研究设计:横断面观察性研究。背景和参与者:从2017年到2023年,4,040名患者转至Necker enfantts - malades医院进行基因检测,检测内容包括:(1)肾小球疾病,(2)纤毛病,(3)肾脏和尿路先天性异常(CAKUT), (4) ADTKD,或(5)不明原因的慢性肾脏疾病(CKD),其中MUC1先前未通过SNaPshot迷你测序进行检测。暴露:临床怀疑ADTKD。结果:使用VNtyper诊断ADTKD-MUC1。分析方法:收集ADTKD- muc1新诊断患者和临床疑似ADTKD患者与非ADTKD患者的数据进行比较。结果:我们通过VNtyper鉴定了40例MUC1变异患者,其中包括33例新指标患者和7例亲属。在33例指标病例中,20例根据临床特征怀疑患有ADTKD,另外13例未考虑ADTKD。在临床未考虑ADTKD的患者中,肾小球疾病患者的检出率为0.05%(1/1895),纤毛病患者的检出率为1.2% (4/329),ckut患者的检出率为0.09%(1/1099),来源不明的CKD患者的检出率为2.5%(7/285)。在6例患者中,没有肾脏疾病的家族史,我们通过分离研究证实了2例患者的新发症状。局限性:观察性研究和选择的转诊人群(可能不代表一般肾脏疾病人群的患病率或表型)。结论:使用VNtyper,我们能够在具有不同表型的大队列患者中诊断ADTKD-MUC1的新病例。一些患者由于另一基因的变异而出现非典型表型,一些患者没有肾脏疾病的家族史,提示有两例患者确诊为新发疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
American Journal of Kidney Diseases
American Journal of Kidney Diseases 医学-泌尿学与肾脏学
CiteScore
20.40
自引率
2.30%
发文量
732
审稿时长
3-8 weeks
期刊介绍: The American Journal of Kidney Diseases (AJKD), the National Kidney Foundation's official journal, is globally recognized for its leadership in clinical nephrology content. Monthly, AJKD publishes original investigations on kidney diseases, hypertension, dialysis therapies, and kidney transplantation. Rigorous peer-review, statistical scrutiny, and a structured format characterize the publication process. Each issue includes case reports unveiling new diseases and potential therapeutic strategies.
期刊最新文献
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY Trajectories of Experiences and Health-Related Quality of Life of Informal Caregivers of Home and In-Center Dialysis Patients: A Multicenter Longitudinal Cohort Study Care Processes and Clinical Responses to Newly Detected Albuminuria: The Stockholm Creatinine Measurements (SCREAM) Project Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy Current and Future Therapeutics for Focal Segmental Glomerular Sclerosis in the Era of Precision Medicine: A Review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1